IPN goes super Sonic
Tuesday, 16 September, 2008
The proposed acquisition of the Independent Practitioner Network [ASX: IPN] by Sonic Healthcare [ASX: SHL] has been approved by IPN shareholders and will go ahead.
The companies received Federal Court approval to proceed with the merger yesterday.
IPN operates over 90 multidisciplinary medical practices in Australia. Sonic runs a number of pathology labs throughout the world, including Douglass Hanly Moir.
Under the arrangement, IPN shareholders will be given cash payments of $0.27 per share, just over the company's current trading price.
Sonic will take possession of all IPN shares on September 30.
Depression impacts energy at a cellular level, researchers find
Depression symptoms may be rooted in fundamental changes in the way brain and blood cells use...
Are discarded peanut shells the affordable and sustainable path to graphene?
Australian researchers have produced small quantities of high-quality graphene via a new process...
Aussie biotech to manufacture mRNA paediatric brain cancer vaccines
A Queensland-based biotechnology company will manufacture personalised mRNA paediatric brain...
